Cancer drug safety test: will it mix with your meds?
NCT ID NCT07340190
Summary
This early-stage study aims to understand how a new cancer drug called pelabresib interacts with three common medications: a diabetes drug, a sedative, and a birth control pill. Researchers will enroll 24 adults with advanced cancers who have run out of standard treatment options. The main goal is to measure how pelabresib changes the levels of these other drugs in the blood to ensure future patients can take them safely together.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.